Dietger Niederwieser

Research interests

Publications

• Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

  Blood · 2022 · https://doi.org/10.1182/blood.2022016867

• Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1917635

• Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

  The Lancet · 2019 · 10.1016/s0140-6736(19)32556-5

• Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

  Blood · 2019 · https://doi.org/10.1182/blood.2019002697

• International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study

  The Lancet Haematology · 2019 · https://doi.org/10.1016/s2352-3026(19)30166-8

• Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

  Blood · 2017 · https://doi.org/10.1182/blood-2016-06-724500

• Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

  New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1614359

• Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

  Blood · 2016 · https://doi.org/10.1182/blood-2016-08-733196

• One million haemopoietic stem-cell transplants: a retrospective observational study

  The Lancet Haematology · 2015 · 10.1016/s2352-3026(15)00028-9

• Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group

  Leukemia · 2015 · https://doi.org/10.1038/leu.2015.233

• Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib

  Blood · 2013 · https://doi.org/10.1182/blood-2013-06-510396

• European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

  Blood · 2013 · https://doi.org/10.1182/blood-2013-05-501569

• Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm—Combined Prospective Analysis by the German AML Intergroup

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2012.42.2907

• The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

  Nature Reviews Clinical Oncology · 2012 · 10.1038/nrclinonc.2012.150

• Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up

  Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2010.32.7312

• Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

  Blood · 2009 · https://doi.org/10.1182/blood-2009-07-235358

• Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome

  Transplantation and Cellular Therapy · 2009 · https://doi.org/10.1016/j.bbmt.2009.08.024

• Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

  Bone Marrow Transplantation · 2009 · 10.1038/bmt.2009.141

• Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

  Blood · 2009 · 10.1182/blood-2009-07-234880

• Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

  Journal of Clinical Oncology · 2009 · 10.1200/jco.2009.25.0779

• Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

  Leukemia · 2008 · https://doi.org/10.1038/leu.2008.84

• Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group

  Haematologica · 2007 · https://doi.org/10.3324/haematol.10699

• Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment

  Blood · 2007 · https://doi.org/10.1182/blood-2007-07-103523

• Allogeneic hematopoietic cell transplantation for metastatic breast cancer

  Bone Marrow Transplantation · 2007 · 10.1038/sj.bmt.1705940

• Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus

  Leukemia · 2006 · 10.1038/sj.leu.2404441

• Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

  Blood · 2006 · https://doi.org/10.1182/blood-2006-09-047266

• Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)

  Leukemia · 2005 · 10.1038/sj.leu.2403967

• Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

  Blood · 2003 · 10.1182/blood-2002-05-1340

• Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

  New England Journal of Medicine · 2002 · 10.1056/nejmoa011573

• Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

  Blood · 2001 · 10.1182/blood.v97.11.3390

• Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres

  British Journal of Haematology · 2001 · https://doi.org/10.1046/j.1365-2141.2001.02726.x

• Generation of mature dendritic cells from human blood An improved method with special regard to clinical applicability

  Journal of Immunological Methods · 1996 · https://doi.org/10.1016/0022-1759(96)00078-6

• Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]

  Blood · 1995 · https://doi.org/10.1182/blood.v86.5.2041.bloodjournal8652041

• Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.

  The Journal of Experimental Medicine · 1984 · 10.1084/jem.160.1.310

Current projects

No projects listed.